STEM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stem Inc is not a strong buy for a beginner investor with a long-term focus at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Insider selling has significantly increased, and analysts have consistently lowered price targets, maintaining neutral ratings. While the technical indicators show some short-term bullishness, the lack of positive catalysts and poor financial trends make this stock unsuitable for long-term investment currently.
The MACD histogram is positive and expanding (0.301), indicating short-term bullish momentum. RSI is at 72.143, which is neutral but nearing overbought territory. Moving averages are converging, suggesting indecision in the market. Key resistance levels are R1: 10.634 and R2: 11.247, while support levels are S1: 8.647 and S2: 8.034.
The MACD indicates short-term bullish momentum, and the pre-market price is up 0.75%.
Insiders are selling heavily, with a 2537.06% increase in selling activity over the last month. Analysts have consistently lowered price targets and maintain neutral ratings. Financial performance in the latest quarter shows significant declines in revenue (-15.55% YoY), net income (-68.75% YoY), and EPS (-69.90% YoY). Gross margin has also dropped sharply (-1473.70% YoY).
In Q4 2025, revenue dropped to $47.14M (-15.55% YoY), net income fell to -$15.98M (-68.75% YoY), and EPS decreased to -1.89 (-69.90% YoY). Gross margin declined significantly to 50.14 (-1473.70% YoY), indicating worsening profitability.
Analysts have lowered price targets multiple times recently: Susquehanna reduced the target to $10 from $21, UBS to $12 from $18, and Roth Capital to $12 from $23. All maintain neutral ratings, citing concerns over visibility into sustained earnings acceleration despite some positive guidance.
